{
    "organizations": [],
    "uuid": "3a4c74cce8f8d3811486cabfc36754c26faeaefd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bradley-thomas-sorenson-reports-56/brief-bradley-thomas-sorenson-reports-5-6-pct-stake-in-arcturus-therapeutics-as-of-nov-16-2017-idUSFWN1PE0DI",
    "ord_in_thread": 0,
    "title": "Bradley Thomas Sorenson Reports 5.6 Pct Stake In Arcturus Therapeutics As Of Nov. 16, 2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 19 (Reuters) - Bradley Thomas Sorenson:\n* BRADLEY THOMAS SORENSON REPORTS 5.6 PERCENT STAKE IN ARCTURUS THERAPEUTICS LTD AS OF NOVEMBER 16, 2017 - SEC FILING\n* BRADLEY THOMAS SORENSON - PURCHASED ARCTURUS THERAPEUTICS' SHARES BASED ON BELIEF THAT SUCH SECURITIES, WHEN PURCHASED, WERE \"UNDERVALUED\" Source text ( bit.ly/2DvO0lA ) Further company coverage:\n ",
    "published": "2018-01-19T19:10:00.000+02:00",
    "crawled": "2018-01-19T13:42:44.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "bradley",
        "thomas",
        "sorenson",
        "bradley",
        "thomas",
        "sorenson",
        "report",
        "percent",
        "stake",
        "arcturus",
        "therapeutic",
        "ltd",
        "november",
        "sec",
        "filing",
        "bradley",
        "thomas",
        "sorenson",
        "purchased",
        "arcturus",
        "therapeutic",
        "share",
        "based",
        "belief",
        "security",
        "purchased",
        "undervalued",
        "source",
        "text",
        "company",
        "coverage"
    ]
}